CHG-2021-0212

Specification Change for Verasenib. Facility Change for Verasenib — major revision. Impacts 4 markets and 4 variations.

Change Number
CHG-2021-0212
Type
Specification Change
Product
Verasenib
Status
Failed
Owner
James O'Brien
Initiated
2023-07-02
Description

Facility Change for Verasenib — major revision

Impacted Markets (4)
US — United StatesAU — AustraliaIT — ItalyKR — South Korea
Impacted Modules
2.3.P5.3.5
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved